High-Sensitivity Troponin I, C - reactive protein, and Hypercholesterolemia as Predictors of Acute Cardiovascular Events in Morocco
Authors:
- Essenhaji SanaaESEssenhaji Sanaa
- Anaibar Fatima EzzahraAEAnaibar Fatima Ezzahra
- Kabine MostafaKMKabine Mostafa
- Houari ChaymaaHCHouari Chaymaa
Open Access
- 30 September 2025
- journal article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 18 (3) , 2452-2462
Abstract
The prevalence of cardiovascular diseases (CVDs) is steadily rising in Morocco and across North Africa, largely linked to dyslipidemia and persistent inflammatory states. This study was conducted to evaluate lipid profiles alongside High-Sensitivity Troponin I (hs-cTnI) and C-Reactive Protein (CRP) levels. A cohort of 240 healthy individuals served as controls, compared with 351 patients diagnosed with acute CVD. Patients exhibited significantly higher levels of LDL-C (1.48 ± 0.45 g/L vs. 1.14 ± 0.24 g/L), hs-cTnI (10.2 ± 5.3 ng/mL vs. 3.1 ± 1.8 ng/mL), and CRP (9.8 ± 7.9 mg/L vs. 2.4 ± 1.6 mg/L), with all differences reaching statistical significance (p < 0.001). Multivariate logistic regression analysis identified LDL-C, hs-cTnI, and CRP as independent predictors of acute CVD, with odds ratios (OR) of 1.82 (95% CI: 1.45-2.29), 1.06 (95\% CI: 1.03-1.09), and 1.12 (95\% CI: 1.04-1.21), respectively Receiver Operating Characteristic (ROC) curve analysis showed that hs-cTnI had moderate discriminative ability (AUC = 0.70), whereas CRP displayed limited predictive performance (AUC = 0.62). These findings suggest that hs-cTnI, and to a lesser extent CRP, may enhance risk stratification for acute CVD in Moroccan populations, highlighting the need for biomarker-guided protocols that are both effective and resource-conscious in clinical practice.Keywords
This publication has 42 references indexed in Scilit:
- Circulating Vegetable Omega-3 and Prognosis in Patients With Heart FailureJACC, 2023
- Risk Scores for Mortality Prediction After Transcatheter Mitral Valve RepairJACC, 2022
- Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyThe Lancet, 2020
- Wingless‐type inducible signaling pathway protein‐1 (WISP1) adipokine and glucose homeostasisJournal of Cellular Physiology, 2019
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsThe Lancet, 2019
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisJACC, 2018
- Association entre des variations de la lipoprotéine lipase et la maladie coronarienne dans une population tunisiennePathologie Biologie, 2012
- Lipid transfers to HDL are predictors of precocious clinical coronary heart diseaseClinica Chimica Acta, 2012
- Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery diseaseClinica Chimica Acta, 2008
- Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseasesFrontiers in Neuroendocrinology, 2008